Inventor · disambiguated record
Manuel A. Navia
Also filed as: NAVIA MANUEL · NAVIA MANUEL A
19 granted patents·19 pending applications·432 citations·filing 1993–2025
95Inventor score
Files withELIXIR PHARMACEUTICALS INC6VERTEX PHARMA6ENCLEAR THERAPIES INC5EXITHERA PHARMACEUTICALS INC4PLIVA D D3
Top patents by PatentIndex Score
38 records- 0192US11278657B2Methods of amelioration of cerebrospinal fluid and devices and systems thereforENCLEAR THERAPIES INC·Filed 2020·Granted Mar 22, 2022·7 cites·29 claims
- 0292US6011001AMethod of protein therapy by orally administering crosslinked protein crystalsVERTEX PHARMA·Filed 1995·Granted Jan 4, 2000·113 cites·4 claims
- 0391US5976529AMethods of enzyme therapy by orally administering crosslinked enzyme crystalsVERTEX PHARMA·Filed 1995·Granted Nov 2, 1999·62 cites·8 claims
- 0489US12084414B2Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2021·Granted Sep 10, 2024·1 cites·13 claims
- 0589US11198673B2Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2019·Granted Dec 14, 2021·3 cites·9 claims
- 0688US5618710ACrosslinked enzyme crystalsVERTEX PHARMA·Filed 1993·Granted Apr 8, 1997·86 cites·13 claims
- 0787US9499532B2Therapeutic compounds and compositionsEXLTHERA PHARMACEUTICALS INC·Filed 2015·Granted Nov 22, 2016·7 cites·22 claims
- 0887US7501404B2Substituted azetidinonesDAIMED·Filed 2006·Granted Mar 10, 2009·21 cites·17 claims
- 0986US10259785B2Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2018·Granted Apr 16, 2019·4 cites·10 claims
- 1085US7829589B2Sulfonamide compounds and uses thereofELIXIR PHARMACEUTICALS INC·Filed 2006·Granted Nov 9, 2010·12 cites·16 claims
- 1185US2025214931A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1284US9994521B2Therapeutic compounds and compositionsEXLTHERA PHARMACEUTICALS INC·Filed 2016·Granted Jun 12, 2018·4 cites·18 claims
- 1380US5849296ACrosslinked protein crystalsVERTEX PHARMA·Filed 1995·Granted Dec 15, 1998·48 cites·15 claims
- 1474US2025312524A1Methods of amelioration of cerebrospinal fluid and devices and systems thereforENCLEAR THERAPIES INC·Filed 2025·Application pending·0 cites
- 1573US6004768ABiosensors, extracorporeal devices and methods for detecting substances using crosslinked protein crystalsVERTEX PHARMA·Filed 1995·Granted Dec 21, 1999·32 cites·32 claims
- 1668US5801022AMethod of producing a product with crosslinked crystals of thermolysinVERTEX PHARMA·Filed 1995·Granted Sep 1, 1998·25 cites·25 claims
- 1767US7504506B2Therapeutic compounds and uses thereofELIXIR PHARMACEUTICALS INC·Filed 2004·Granted Mar 17, 2009·3 cites·10 claims
- 1863US11419921B2Methods of treating neurological disordersENCLEAR THERAPIES INC·Filed 2021·Granted Aug 23, 2022·0 cites·22 claims
- 1963US2023056486A1Methods of treating neurological disordersENCLEAR THERAPIES INC·Filed 2022·Application pending·0 cites
- 2062US7345048B2Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitorsPLIVA D D·Filed 2002·Granted Mar 18, 2008·4 cites·22 claims
- 2161US2009143351A1Substituted azetidinonesDAIAMED·Filed 2009·Application pending·0 cites
- 2259US7897765B2Therapeutic compounds and uses thereofELIXIR PHARMACEUTICALS INC·Filed 2009·Granted Mar 1, 2011·0 cites·35 claims
- 2351US11752200B2Methods of treating neurological disordersENCLEAR THERAPIES INC·Filed 2021·Granted Sep 12, 2023·0 cites·8 claims
- 2450US2011190252A1Compositions including clavulanic acid and related methods of useWATSON ALAN·Filed 2009·Application pending·0 cites
- 2549US2007207512A1Structure-based drug design methods for identifying d-ala-d-ala ligase inhibitors as antibacterial drugsPLIVA D D·Filed 2006·Application pending·0 cites
- 2649US2008214800A1Sirt inhibitors that bind to nadELIXIR PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2748US2003119061A1Structure-based drug design methods for identifying D-Ala-D-Ala ligase inhibitors as antibacterial drugsFiled 2002·Application pending·0 cites
- 2848US2008090847A1Heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitorsPLIVA D D·Filed 2007·Application pending·0 cites
- 2945US2010144698A1Substituted azetidinonesDAIAMED·Filed 2010·Application pending·0 cites
- 3042US2011152232A1Sulfonamide compounds and uses thereofSAUNDERS JEFFREY O·Filed 2010·Application pending·0 cites
- 3142US2006293370A1Sulfonamide compounds and uses thereofSAUNDERS JEFFREY O·Filed 2006·Application pending·0 cites
- 3240US2005261332A1Sulfonamides and uses thereofDISTEFANO PETER·Filed 2005·Application pending·0 cites
- 3339US2006019952A1Anti-viral therapeuticsELIXIR PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3439US2005256181A1Treating a viral disorderELIXIR PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3535US2013029980A1Flavin derivativesCOISH PHILIP D G·Filed 2011·Application pending·0 cites
- 3633US2012283219A1Diaminopteridine derivativesCOISH PHILIP D G·Filed 2010·Application pending·0 cites
- 3730US2012295903A1Flavin derivativesBLOUNT KENNETH F·Filed 2010·Application pending·0 cites
- 3830US2003166645A1Novel nitrofuran-containing heterocyclic compounds and uses thereofFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →